Letter to Editor on 'A randomized, controlled, blinded, parallel-group, clinical trial to study the role of Ayurcov (AyurCoro3), a one-day regimen as an adjuvant therapy for COVID-19 disease management, at dedicated Covid Hospital (DCH) in India'
Saved in:
| Main Authors: | , , |
|---|---|
| Format: | Book |
| Published: |
Elsevier,
2022-09-01T00:00:00Z.
|
| Subjects: | |
| Online Access: | Connect to this object online. |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
MARC
| LEADER | 00000 am a22000003u 4500 | ||
|---|---|---|---|
| 001 | doaj_fbf7989aff3b4f6790b534b5ff11cfb3 | ||
| 042 | |a dc | ||
| 100 | 1 | 0 | |a Bharat Krushna Khuntia |e author |
| 700 | 1 | 0 | |a Aman Agarwal |e author |
| 700 | 1 | 0 | |a Gautam Sharma |e author |
| 245 | 0 | 0 | |a Letter to Editor on 'A randomized, controlled, blinded, parallel-group, clinical trial to study the role of Ayurcov (AyurCoro3), a one-day regimen as an adjuvant therapy for COVID-19 disease management, at dedicated Covid Hospital (DCH) in India' |
| 260 | |b Elsevier, |c 2022-09-01T00:00:00Z. | ||
| 500 | |a 0965-2299 | ||
| 500 | |a 10.1016/j.ctim.2022.102838 | ||
| 546 | |a EN | ||
| 690 | |a Ayurveda | ||
| 690 | |a COVID-19 | ||
| 690 | |a Other systems of medicine | ||
| 690 | |a RZ201-999 | ||
| 655 | 7 | |a article |2 local | |
| 786 | 0 | |n Complementary Therapies in Medicine, Vol 68, Iss , Pp 102838- (2022) | |
| 787 | 0 | |n http://www.sciencedirect.com/science/article/pii/S0965229922000401 | |
| 787 | 0 | |n https://doaj.org/toc/0965-2299 | |
| 856 | 4 | 1 | |u https://doaj.org/article/fbf7989aff3b4f6790b534b5ff11cfb3 |z Connect to this object online. |